Preterm babies at higher risk of long-term neurodevelopmental issues, study finds

Children born moderately (32-33 weeks) or late preterm (34-36 weeks) have higher long-term risks of neurodevelopmental difficulties that can affect their behavior and ability to learn, finds a study of over one million children published by The BMJ today.

Q&A: Ken Song details RayzeBio’s path from Series A to IPO in 3 years, taking a down round and being disciplined

Ken Song almost never got into radiopharmaceuticals. But after back-to-back phone calls from venture capital leaders at Versant and venBio in March 2020, the repeat

March 6, 2024

Researchers seek early Alzheimer’s detection with MRSI

University of Virginia professor Mathews Jacob has secured a $3.9 million grant to advance his innovative research on detecting Alzheimer’s disease in its early stages.

September 14, 2024

Lasers, cardiology, clinical trials: 2023’s top private equity targets

By some measures, private equity investment lagged in 2023, a year marked by growing distress and high-profile downfalls among private equity-backed health care companies. Even

February 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.